This webinar, hosted by Patrick Short, CEO of Sano Genetics, and featuring Dr. Mark Kotter, CEO of bit.bio, focused on precision medicine in multiple sclerosis....
Continue reading
This webinar, hosted by Sano Genetics and featuring representatives from Newcastle University, Congenica, UK CRC Tissue Directory and Co-ordination Centre and S...
Continue reading
This webinar was hosted by Sano Genetics' scientific advisor, Paul Wicks, and featured representatives from Genomics England as well as Sage Bionetworks. The di...
Continue reading
Decentralized and hybrid clinical trials hold significant promise for improving access and reducing patient burden. But implementing them introduces operational...
Continue reading
In this webinar, Patrick Short (Co-Founder and CEO at Sano Genetics) and Will Jones (Co-Founder and CTO at Sano Genetics) discuss the technical challenges of bi...
Continue reading
Recruitment remains one of the most consequential operational challenges in clinical research. This article examines the structural factors that drive enrollmen...
Continue reading
Patient experience is far more than a performance metric. It is a structural factor that shapes enrollment, retention, and the long-term quality of clinical res...
Continue reading
Sano raises $11 million in Series A funding round led by MMC Ventures New funding will support the team to grow and further its mission to accelerate personalis...
Continue reading
Virtual and decentralized trial models have moved from emergency workaround to strategic default for many precision medicine programs. This article examines whe...
Continue reading
Sano Genetics supports personalised medicine research by increasing participation in clinical trials and guiding patients through the process Half of clinical t...
Continue reading